Abeona Therapeutics Inc. (ABEO) Social Stream



Abeona Therapeutics Inc. (ABEO): $0.16

-0.01 (-7.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Abeona Therapeutics Inc (ABEO) Price Targets From Analysts

Use the tables below to see what analysts covering Abeona Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 2 $5 $5 $5 $0.329 1419.76%
2021-11-18 3 $5 $5 $5 $0.329 1419.76%
2021-11-29 3 $5 $4 $4.666 $0.329 1318.24%
2021-11-30 3 $5 $1 $3.333 $0.329 913.07%
2022-03-31 3 $4 $1 $3 $0.329 811.85%

The Trend in the Analyst Price Target


Over the past 22 months, ABEO's average price target has gone down $6.43.

Over the past 51 weeks, ABEO's average upside potential has been 373.54%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 1 8 4 5.67 1.820 211.54%
2021-10-21 2 5 5 5.00 0.904 453.1%
2021-11-15 2 5 5 5.00 0.911 448.85%
2021-11-18 3 5 5 5.00 0.767 551.89%
2021-12-23 3 4 1 3.00 0.361 731.02%

ABEO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


ABEO's average broker recommendation rating improved by 0.08 over the prior 13 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABEO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Abeona Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 495.78% of them.
  • To contextualize these metrics, consider that out of all US stocks, Abeona Therapeutics Inc's average analyst price target is higher than 10.48% of them.
  • In terms of how Abeona Therapeutics Inc fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -92.13% of that group.
  • Abeona Therapeutics Inc's number of analysts covering the stock is higher than 54.89% of Healthcare stocks.

Stocks similar to Abeona Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VIGL, TCRX, and TCON.

Is ABEO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6585 seconds.